1Shi-Chun Lu, Lu-Nan Yan, Bo Li, Tian-Fu Wen, Ji-Chun Zhao, Nan-Sheng Cheng, Chong Liu, Jun Liu, Xiao-Bo Wang, Xiao-Dong Li, Shan Qin, Lian-Shan Zhao, Bin-Jun Lei and Xiu-Hui Zhang Chengdu, China Department of Surgery ,Viral Hepa- titis Research Center ,Department of Pathology , West China Hospital, Sichuan University, Cheng- du 610041 , China.Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):26-32. 被引量：9
2Fung JJ, Rao AS, Molmenti DEP, et al. Future of transplantation(including xenografting). 4th edition. Philadelphia: WB Saunders Company, 2000: 1997-2008
3Starzl TE, Rao AS, Murase N, et al. Will xenotransplantation ever be feasible? J Am Coil Surg, 1998,186(4):383-387
4Starzl TE, Fung J, Tzakis A, et al. Baboon-to-human liver transplantation. Lancet, 1993,341(8837):65-71
5Fung J J, Eliasziw M, Todo S, et al. The pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation.J Am Coil Surg, 1996,183(2):117-125
6Mihatsch M J, Kyo M, Morozumi K, et al. The side effects of cyclosporine A and tacrolimus. Clin Nephrol, 1998,49(6):356-363
